» Articles » PMID: 35213359

Predicting Pancreatic Ductal Adenocarcinoma Using Artificial Intelligence Analysis of Pre-diagnostic Computed Tomography Images

Overview
Journal Cancer Biomark
Publisher Sage Publications
Specialties Biochemistry
Oncology
Date 2022 Feb 25
PMID 35213359
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Early stage diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) is challenging due to the lack of specific diagnostic biomarkers. However, stratifying individuals at high risk of PDAC, followed by monitoring their health conditions on regular basis, has the potential to allow diagnosis at early stages.

Objective: To stratify high risk individuals for PDAC by identifying predictive features in pre-diagnostic abdominal Computed Tomography (CT) scans.

Methods: A set of CT features, potentially predictive of PDAC, was identified in the analysis of 4000 raw radiomic parameters extracted from pancreases in pre-diagnostic scans. The naïve Bayes classifier was then developed for automatic classification of CT scans of the pancreas with high risk for PDAC. A set of 108 retrospective CT scans (36 scans from each healthy control, pre-diagnostic, and diagnostic group) from 72 subjects was used for the study. Model development was performed on 66 multiphase CT scans, whereas external validation was performed on 42 venous-phase CT scans.

Results: The system achieved an average classification accuracy of 86% on the external dataset.

Conclusions: Radiomic analysis of abdominal CT scans can unveil, quantify, and interpret micro-level changes in the pre-diagnostic pancreas and can efficiently assist in the stratification of high risk individuals for PDAC.

Citing Articles

Diagnostic Accuracy of Radiomics in the Early Detection of Pancreatic Cancer: A Systematic Review and Qualitative Assessment Using the Methodological Radiomics Score (METRICS).

Renjifo-Correa M, Fanni S, Bustamante-Cristancho L, Cuibari M, Aghakhanyan G, Faggioni L Cancers (Basel). 2025; 17(5).

PMID: 40075651 PMC: 11898638. DOI: 10.3390/cancers17050803.


Artificial Intelligence in Pancreatic Imaging: A Systematic Review.

Podina N, Gheorghe E, Constantin A, Cazacu I, Croitoru V, Gheorghe C United European Gastroenterol J. 2025; 13(1):55-77.

PMID: 39865461 PMC: 11866320. DOI: 10.1002/ueg2.12723.


AI-Driven insights in pancreatic cancer imaging: from pre-diagnostic detection to prognostication.

Antony A, Mukherjee S, Bi Y, Collisson E, Nagaraj M, Murlidhar M Abdom Radiol (NY). 2024; .

PMID: 39738571 DOI: 10.1007/s00261-024-04775-x.


Pancreatic Ductal Adenocarcinoma (PDAC): A Review of Recent Advancements Enabled by Artificial Intelligence.

Mukund A, Afridi M, Karolak A, Park M, Permuth J, Rasool G Cancers (Basel). 2024; 16(12).

PMID: 38927945 PMC: 11201559. DOI: 10.3390/cancers16122240.


Early detection of pancreatic cancer in the era of precision medicine.

Ahmed T, Kawamoto S, Lopez-Ramirez F, Yasrab M, Hruban R, Fishman E Abdom Radiol (NY). 2024; 49(10):3559-3573.

PMID: 38761272 DOI: 10.1007/s00261-024-04358-w.


References
1.
Hart P . Early Detection of Pancreatic Cancer in High-Risk Individuals: Where Do We Go From Here?. Am J Gastroenterol. 2019; 114(4):560-561. PMC: 6450722. DOI: 10.14309/ajg.0000000000000192. View

2.
Singhi A, Koay E, Chari S, Maitra A . Early Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology. 2019; 156(7):2024-2040. PMC: 6486851. DOI: 10.1053/j.gastro.2019.01.259. View

3.
Orth M, Metzger P, Gerum S, Mayerle J, Schneider G, Belka C . Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiat Oncol. 2019; 14(1):141. PMC: 6688256. DOI: 10.1186/s13014-019-1345-6. View

4.
Nolen B, Brand R, Prosser D, Velikokhatnaya L, Allen P, Zeh H . Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. PLoS One. 2014; 9(4):e94928. PMC: 3991628. DOI: 10.1371/journal.pone.0094928. View

5.
Kleeff J, Korc M, Apte M, La Vecchia C, Johnson C, Biankin A . Pancreatic cancer. Nat Rev Dis Primers. 2016; 2:16022. DOI: 10.1038/nrdp.2016.22. View